Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA final latex skin sensitivity testing guidance revises condom label claims, warnings.

This article was originally published in The Tan Sheet

Executive Summary

FDA FINAL LATEX SENSITIVITY GUIDANCE REVISES LABELING CLAIMS including reduction of the potential for skin reactions. The agency's "final revised draft" allows manufacturers of latex-containing medical products, including natural rubber latex condoms, to carry claims on the reduced potential for inducing chemical sensitization in unsensitized individuals and the reduced potential for eliciting a reaction in sensitized individuals. Comments on the Feb. 13 guidance are due in 30 days.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088144

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel